Notice 12 May 2025 co-investment, regulatory compliance, sec, investment companies, business development companies

⚖️SEC Notice on Joint Transactions for Investment Companies

The SEC has issued a notice regarding an application from Morgan Stanley and others, seeking permission for certain joint transactions prohibited under the Investment Company Act of 1940. The order would enable collaboration among business development companies and affiliated entities, potentially reshaping investment strategies and regulatory requirements in this sector.

Learn More
Notice 12 May 2025 health, patent extension, drug approval, regulatory compliance, fda, pharmaceutical

💊FDA Notices Regulatory Review Period for JAYPIRCA Patent Extension

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for JAYPIRCA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.

Learn More
Proposed Rule 12 May 2025 animals, usda, agricultural commodities, mushrooms, seals and insignia, pet food, administrative practice and procedure, labeling, organically produced products, reporting and recordkeeping requirements, fees, plants, organic, archives and records, soil conservation, regulatory compliance, agriculture, imports, livestock

🍄Proposed Rescind of National Organic Program for Mushrooms & Pet Food

AMS is proposing to rescind the rule and regulations issued on December 23, 2024, titled, "National Organic Program; Market Development for Mushrooms and Pet Food."

Learn More
Notice 12 May 2025 public comments, information collection, regulatory compliance, veterans affairs

📄VA Notice on Application Request to Add/Remove Dependents

Veterans Benefits Administration (VBA), Department of Veterans Affairs (VA), is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act (PRA) of 1995, Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed revision of a currently approved collection, and allow 60 days for public comment in response to the notice.

Learn More
Notice 12 May 2025 finance, regulatory compliance, legal services, line of credit, board meetings

🏦Update on Legal Services Corporation's Sunshine Act Meeting

The Legal Services Corporation announced changes to its Sunshine Act meeting, closing part of the session to discuss internal activities and a resolution regarding the corporation's line of credit agreement. The meeting emphasizes transparency and governance within the organization while addressing financial matters that could impact operations and funding.

Learn More
Notice 12 May 2025 finance, regulatory compliance, technology adoption, digitalization, community banks

💻OCC's Request for Information on Community Bank Digitalization

To build on its understanding, OCC is issuing a request for information (RFI) on community bank engagement with digitalization. The RFI solicits comment on the key challenges and barriers faced by community banks in the adoption and implementation of digital banking solutions.

Learn More
Notice 12 May 2025 biotechnology, patent extension, regulatory compliance, pharmaceuticals, fda

💊FDA Regulatory Review Period Determination for LAMZEDE Patent Extension

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for LAMZEDE and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.

Learn More
Notice 12 May 2025 ngenla, health products, patent extension, regulatory compliance, fda, pharmaceutical

💊FDA Notice on NGENLA Regulatory Review Period and Patent Extension

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for NGENLA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.

Learn More
Notice 12 May 2025 information collection, tribal assistance, regulatory compliance, bureau of indian affairs, housing improvement program

🏡Bureau of Indian Affairs Information Collection on Housing Improvement Program

In accordance with the Paperwork Reduction Act of 1995, we, the Bureau of Indian Affairs (BIA) are proposing to renew an information collection.

Learn More
Notice 12 May 2025 federal register, information collection, regulatory compliance, child custody, indian affairs

📄Public Comments Requested on Tribal Child Custody Jurisdiction Notice

In accordance with the Paperwork Reduction Act of 1995, we, the Bureau of Indian Affairs (BIA), are proposing to renew an information collection.

Learn More